Column Group
Venture Capital
The Column Group (TCG) is a science-driven venture capital firm building early-stage life sciences companies through an edge-to-edge investment model from inception to exit.
Seed
Early Stage
Biotech
Life Sciences
- Headquarters
- San Francisco, United States
- Website
- thecolumngroup.com
- AUM
- $4.2B
- Last Investment
- Dec 2014
- Geographic Focus
- United States
Investment Thesis
Deploys ecosystem of funds to advance biology, chemistry, and technology innovations into therapeutic breakthroughs.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account